Kelley Drye is mentioned in a Life & Sciences Law & Industry Report article titled “Court Enjoins Nov. 1 Implementation of New Patent Rules.” The article refers to Kelley Drye’s representation of Dr. Triantafyllos Tafas in the lawsuit challenging the United Stated Patent and Trademark Office (USPTO) rules regarding continuation applications and claims a patent applicant may file. The article praises the decision and reports that the plaintiffs, GlaxoSmithKline and Dr. Tafas, are likely to prevail in the suit. It notes that in December Kelley Drye will take USPTO Director Jon Dudas’s depositions.

Life & Sciences Law & Industry Report Cites Kelley Drye’s Representation of Dr. Tafas in USPTO Lawsuit